Testing effectiveness (Phase 2)WithdrawnNCT01649622What this trial is testingBendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)Who this might be right forLeukemiaLymphoma M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002502What this trial is testingCombination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT02228772What this trial is testingPhase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older AdultsWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic LymphomaB-cell Adult Acute Lymphoblastic Leukemia+1 more Massachusetts General Hospital 19
Early research (Phase 1)Study completedNCT00003395What this trial is testingArsenic Trioxide in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05157971What this trial is testingVenetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaPh-Like Acute Lymphoblastic Leukemia City of Hope Medical Center 24
Testing effectiveness (Phase 2)UnknownNCT06078306What this trial is testingCD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).Who this might be right forB Acute Lymphoblastic LeukemiaPh-Negative ALLHigh Risk Acute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05480449What this trial is testingAutologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)Who this might be right forB Cell Acute Lymphoblastic Leukemia (B-ALL)B Lineage Lymphoblastic Lymphoma Stephan Grupp MD PhD 115
Testing effectiveness (Phase 2)Looking for participantsNCT06985485What this trial is testingFull-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline ChemotherapyWho this might be right forAcute Lymphoblastic LeukemiaImmunotherapyBlinatumomab+1 more The First Affiliated Hospital of Soochow University 26
Testing effectiveness (Phase 2)Study completedNCT00049504What this trial is testingHaploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+94 more Fred Hutchinson Cancer Center 53
Not applicableActive Not RecruitingNCT07269587What this trial is testingA Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19Who this might be right forALL (Acute B-Lymphoblastic Leukemia)CAR-T Cell Therapy Ruijin Hospital 275
Not applicableLooking for participantsNCT01137643What this trial is testingTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more UNC Lineberger Comprehensive Cancer Center 15,000
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Testing effectiveness (Phase 2)Looking for participantsNCT05735717What this trial is testingMT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesWho this might be right forHematologic MalignancyAcute LeukemiaRemission+21 more Masonic Cancer Center, University of Minnesota 70
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Not applicableLooking for participantsNCT06343090What this trial is testingClinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL PatientsWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoid Leukemia Beijing GoBroad Hospital 353
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Testing effectiveness (Phase 2)Looking for participantsNCT05031897What this trial is testingTwo Step Haplo With Radiation ConditioningWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdult T-Cell Leukemia/Lymphoma+14 more Thomas Jefferson University 63
Very early researchEnded earlyNCT04034446What this trial is testingCD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)Who this might be right forRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia Institute of Hematology & Blood Diseases Hospital, China 2
Early research (Phase 1)Study completedNCT00005988What this trial is testingBone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Dana-Farber Cancer Institute 5